ArticleDrug metabolism and disposition: the biological fate of chemicals2025
Rat PermQ: A permeability- and perfusion-based physiologically based pharmacokinetic model for improved prediction of drug concentration-time profiles in rat.
Article in Drug metabolism and disposition: the biological fate of chemicals, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modeling Metabolite Kinetics with a Partial Differential Equation-Based Hepatic Sinusoidal Model and MALDI-Mass Spectrometry Imaging of Verapamil and Its Metabolites.Journal of medicinal chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A new rat permeability- and perfusion-limited physiologically based pharmacokinetic model, "rat PermQ," was developed with the goal of improving concentration-time (C-t) predictions of drugs. Similar to the previously published human PermQ, drugs can reversibly distribute between capillaries and interstitial fluid by fenestra or discontinuities in capillaries or by transcellular diffusion through endothelial cells. Drugs also can be partitioned into intracellular phospholipids and neutral lipids in the cytosol. For acidic drugs, active uptake transport and an empirical protein binding correction factor were considered. A shallow distribution compartment was added for basic drugs to account for early distribution. In vitro and in vivo experimental inputs were collected in-house or from the literature. C-t profiles were predicted for 7 drugs (2 acidic, 2 neutral, and 3 basic) with 3 models: Rodgers and Rowland (RR), a perfusion-limited membrane-based model, and rat PermQ. Results indicate the importance of consistent, species-specific in vitro inputs. In general, rat PermQ predicted C-t profiles at least as well as the other models. For acidic drugs, rat PermQ predictions improved with incorporation of uptake transport and the empirical protein binding factor. For neutral drugs, RR predicted digoxin C-t profiles better compared with rat PermQ, while midazolam predictions with rat PermQ were improved with the use of in-house in vitro experimental inputs. Rat PermQ predicted C-t profiles for all 3 bases better than RR and perfusion-limited membrane-based model, and addition of a shallow compartment greatly improved the predictions. Rat and human PermQ allowed several hypotheses to be simulated for putative uptake mechanisms for atenolol and glyburide. SIGNIFICANCE STATEMENT: A new physiologically based pharmacokinetic framework, rat PermQ, was developed. This model predicted plasma concentration-time profiles of the tested drugs as well as or better than published physiologically based pharmacokinetic models. PermQ allowed several hypotheses to be simulated for uptake mechanisms in rats and humans. The work highlights the importance of accurate in vitro parameters such as drug plasma protein binding and blood-to-plasma ratio. The model can aid in testing new hypotheses to explain poorly understood observations in distribution and elimination of drugs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.